Tilray (TLRY) Medical, a division of Tilray Brands, announced significant updates to its Tilray Medical pricing programs in Canada. These changes are designed to make medical cannabis more accessible for patients nationwide. As part of these updates, Tilray Medical’s Compassionate Pricing program now features an increased annual income eligibility threshold of $65,000 CAD, up from $32,500 CAD, ensuring more patients qualify for support.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLRY:
- Tilray’s Tumultuous Week: Stock Dips Amid Mixed Signals
- Moderately bullish activity in Tilray with shares up 2.71%
- Mixed options sentiment in Tilray with shares down 2.21%
- Tilray to debut brands at American Craft Beer Experience Festival in Japan
- Mixed options sentiment in Tilray with shares down 1.81%